SCHEMBL20054635

SCHEMBL20054635

CNCCNC(C(=O)N1CCC[C@H]1C(=O)Nc1ccc(-c2cnc(-c3ccc(NC(=O)[C@@H]4CCCN4C(=O)C(NCCNC)c4ccccc4)cc3)o2)cc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.55
CYP2C9 P11712 6/20 0.47
CYP2C19 P33261 6/20 0.47
CYP3A4 P08684 5/20 0.47
CYP2D6 P10635 2/20 0.47
CYP1A2 P05177 2/20 0.46
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPK1 P28482 2/20 0.42
GAA P10253 2/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PABPC1 P11940 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2197637 0.87 KCNH2 (0.63) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL2196365 0.85 KCNH2 (0.52) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL2198301 0.84 KCNH2 (0.53) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL2195345 0.84 KCNH2 (0.53) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL2194642 0.83 KCNH2 (0.52) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL2194641 0.83 KCNH2 (0.52) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL2197078 0.83 KCNH2 (0.56) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL2197138 0.83 KCNH2 (0.56) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL16495777 0.83 KCNH2 (0.52) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL12490151 0.82 KCNH2 (0.53) KCNH2CYP2C9CYP2C19CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2802326-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-04-18 EP disclosed